5 diagnostic assay preparations and substances for clinical or medial use; labelled and unlabelled polyclonal and monoclonal antibodies for clinical or medical laboratory use or for environmental analysis for use in the treatment of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; allergen analysis and purification preparations and substances, composed of antibodies, for use in the treatment of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; [ pharmaceutical preparations, namely, epitope mapping systems, composed of antibodies, for use in the treatment of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; pharmaceutical preparations, namely, rapid test devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances; pharmaceutical preparations, namely, allergen detection devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods, or any other substances; ] assay systems, composed of antibodies for detection of antibodies in blood and other body fluids; diagnostic assay systems, composed of antibodies for detection of antibodies in blood and other body fluids; allergen analysis and purification systems, composed of antibodies, for isolation and purification of natural and recombinant allergens for diagnosis and treatment of allergic diseases; epitope mapping systems, composed of antibodies and natural or recombinant allergens, for use in diagnosis and treatment of allergic diseases